This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Eric D. Caine, MD; Ronald J. Polinsky, MD
University of Rochester School of Medicine and Dentistry Departments of Psychiatry and Neurology Rochester, Ny

Section of Medicine Laborator of Clinical Science National Institutes of Health Bethesda, Md 20205

Arch Neurol. 1981;38(7):471-472.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

The note by Mizrahi et al (ARCHIVES 1980;37:780) describing tardive dyskinesia in a child with Gilles de la Tourette's disease (TD) prompts us to report three other cases that we have observed, in addition to one that we reported previously.¹

Report of Cases.—

CASE 1.—An 8-year-old boy first received treatment with haloperidol after referral for the sudden onset of incessant coprolalia. Prior to that time, he had eye tics that began six months after beginning treatment with methylphenidate for symptoms of hyperactivity. His haloperidol dosage was gradually increased to 5 to 6 mg/day, which provided beneficial (but not complete) suppression of tics. Performance in school was unaffected by this dosage, although his family noted increased appetite and weight gain. He was followed up for two years, with regular monitoring of his TD symptoms as well as repeated dosage reduction to evaluate the possible emergence of drug-induced . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?